Zimmer Biomet Holdings, Inc.
ZBH
Classement en actions
#1245
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing... Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Prix de l'action
$95.26
Capitalisation boursière
$18.17B
Changement (1 jour)
-0.71%
Changement (1 an)
-7.24%
Pays
US
Échange Zimmer Biomet Holdings, Inc. (ZBH)
Catégorie
Healthcare
Revenus pour Zimmer Biomet Holdings, Inc. (ZBH)
Revenus en Jun 2026 TTM : $8.51B
Selon les derniers rapports financiers de Zimmer Biomet Holdings, Inc., le chiffre d'affaires actuel de l'entreprise (TTM) est de $8.51B. En 2024, l'entreprise a réalisé un chiffre d'affaires de $7.68B une augmentation par rapport à le chiffre d'affaires de l'année 2023, qui était de $7.39B. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Zimmer Biomet Holdings, Inc. de 2000 à 2026
Revenus à la fin de chaque année
| Année | Revenus | Changez |
|---|---|---|
| 2026 (TTM) | $8.51B | 3.37% |
| 2025 | $8.23B | 7.20% |
| 2024 | $7.68B | 3.85% |
| 2023 | $7.39B | 6.55% |
| 2022 | $6.94B | 1.65% |
| 2021 | $6.83B | 11.42% |
| 2020 | $6.13B | -23.24% |
| 2019 | $7.98B | 0.62% |
| 2018 | $7.93B | 1.66% |
| 2017 | $7.80B | 1.76% |
| 2016 | $7.67B | 27.85% |
| 2015 | $6.00B | 28.34% |
| 2014 | $4.67B | 1.08% |
| 2013 | $4.62B | 3.39% |
| 2012 | $4.47B | 0.45% |
| 2011 | $4.45B | 5.49% |
| 2010 | $4.22B | 3.05% |
| 2009 | $4.10B | -0.62% |
| 2008 | $4.12B | 5.74% |
| 2007 | $3.90B | 11.50% |
| 2006 | $3.50B | 6.37% |
| 2005 | $3.29B | 10.24% |
| 2004 | $2.98B | 56.81% |
| 2003 | $1.90B | 38.52% |
| 2002 | $1.37B | 16.44% |
| 2001 | $1.18B | 13.26% |
| 2000 | $1.04B | 0.00% |
Revenus d’entreprises similaires ou concurrentes
| Entreprise | Revenus | Différence de revenus | Pays |
|---|---|---|---|
| $46.59B | 447.49% |
US
|
|
| $35.48B | 317.02% |
IE
|
|
| $25.84B | 203.65% |
US
|
|
| $21.00B | 146.75% |
US
|
|
| - | - |
DE
|
